The online pharmacy, which offers low-cost common medications, will immediately import and distribute 1.2 million units of penicillin to mitigate the shortage of Pfizer's (PFE.N) Bicillin L-A. Last ...

(Reuters) - Mark Cuban's Cost Plus Drug Company said on Wednesday that it is working with the U.S. Food and Drug Administration to import and distribute penicillin in the country temporarily.

Pfizer, which manufactures the drug, indicated in June that they have enough Bicillin to treat diagnosed cases of the disease. Kramer said the earlier supply limitations of Bicillin L-A hadn’t been an ...

Normally, Pfizer is the only American manufacturer of this specific shot, called Bicillin L-A, but it has been in short supply of that medication for over a year. For now, the US Food and Drug ...

July 17 (Reuters) - (This July 17 story has been corrected to remove the incorrect reference to number of units, and to remove references to Pfizer's pediatric version of Bicillin-L-A, in ...

Pfizer’s Bicillin L-A is the optimal treatment for syphilis Syphilis cases at highest levels since 1950: government data The US shortage of Pfizer Inc. ’s drug that’s the optimal treatment for ...

Doctors then switched to non-generic drugs like Pfizer’s penicillin drug, Bicillin. That drug is itself in short supply due to a surge in syphilis infections in the U.S. Pfizer has increased its ...

The move was approved by the FDA on Wednesday. Bicillin, a long-acting injectable form of penicillin made by Pfizer that is similar to Extencilline, has been in short supply in the United States since ...

In June, Pfizer had warned that it would soon run out of supply of its drug, Bicillin L-A, used to treat syphilis and other bacterial infections in children because it has had to prioritise ...

With U.S. syphilis cases on the rise and Pfizer’s Bicillin treatment still in short supply, France’s Laboratoires Delbert is stepping in to help with temporary imports. The French drugmaker is ...

According to Pfizer, a sufficient supply of Bicillin L-A is expected by the second quarter of 2024.